This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Source of effectiveness data
The clinical and epidemiological data included in the model were:
the treatment effectiveness at inducing remission; the risk of developing minor and major infections after treatment; and the probability of suffering an adverse event leading to discontinuation.
Modelling
A patient level simulation was conducted in order to simulate the costs and outcomes for each treatment. Average costs and outcomes for each treatment were estimated by means of a patient level simulation with 10,000 repetitions. The time horizon of the model was 24 weeks. 
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